Developer of next-generation chronic-pain treatments.
| Date | Round | Amount |
|---|---|---|
| May 2024 | Grant Biodol Therapeutics, a French chronic-pain biotech, was awarded EUR7M by BPI France for first-in-human trials. | $7.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.